AKT1 and non-small cell lung carcinoma: In conclusion, our results suggest that LINC01128/miR-25-3p/PTEN may promote EGFR-TKI resistance via the PI3K/Akt signaling pathway, which helps in elucidating the underlying molecular mechanisms of EGFR-TKI resistance in NSCLC.